Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760095 · ClinicalTrials.gov registry record
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 46
- Enrollment target
NCT02760095 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 46 participants.
The verdict
NCT02760095 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The overall objective is to determine the impact of EED on zinc absorption and homeostasis, and its impact on the absorptive capacity of vitamin A absorption of young children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies.
Interventions
- DRUG 3 mg zinc sulfate supplement
- DRUG 0.5 mg of 13C10-retinyl-acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02760095
The ClinicalTrials.gov registry entry for NCT02760095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3 mg zinc sulfate supplement is the first listed.
NCT02760095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02760095 about?
NCT02760095 is a clinical study titled "Effects of EED on Zn Absorption and Retention in Children From a Standard Dose". The overall objective is to determine the impact of EED on zinc absorption and homeostasis, and its impact on the absorptive capacity of vitamin A absorption of young children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies.
What is the current status of trial NCT02760095?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2015-11. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02760095?
The interventions under investigation include: 3 mg zinc sulfate supplement (DRUG), 0.5 mg of 13C10-retinyl-acetate (DRUG).
Who is sponsoring clinical trial NCT02760095?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.